Cargando…
Fractal-Based Radiomic Approach to Tailor the Chemotherapy Treatment in Rectal Cancer: A Generating Hypothesis Study
INTRODUCTION: The aim of this study was to create a radiomic model able to calculate the probability of 5-year disease-free survival (5yDFS) when oxaliplatin (OXA) is or not administered in patients with locally advanced rectal cancer (LARC) and treated with neoadjuvant chemoradiotherapy (nCRT), all...
Autores principales: | Di Dio, Carmela, Chiloiro, Giuditta, Cusumano, Davide, Catucci, Francesco, Boldrini, Luca, Romano, Angela, Meldolesi, Elisa, Marazzi, Fabio, Corvari, Barbara, Barbaro, Brunella, Manfredi, Riccardo, Valentini, Vincenzo, Gambacorta, Maria Antonietta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695680/ https://www.ncbi.nlm.nih.gov/pubmed/34956893 http://dx.doi.org/10.3389/fonc.2021.774413 |
Ejemplares similares
-
Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the Cure
por: Chiloiro, Giuditta, et al.
Publicado: (2020) -
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology
por: Chiloiro, Giuditta, et al.
Publicado: (2019) -
Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer
por: Chiloiro, Giuditta, et al.
Publicado: (2023) -
Could the conservative approach be considered safe in the treatment of locally advanced rectal cancer in case of a clinical near-complete or complete response? A retrospective analysis
por: Chiloiro, Giuditta, et al.
Publicado: (2021) -
Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach
por: Boldrini, Luca, et al.
Publicado: (2018)